Xbiome Patents – Insights & Stats (Updated 2024)

Xbiome has a total of 11 patents globally, out of which no patents have been granted. Of these 11 patents, all the patents are active. The USA is where Xbiome has filed the maximum number of patents, followed by China and Europe (EPO). Parallelly, China seems to be the main focused R&D centre and also USA is the origin country of Xbiome.

Xbiome was founded in 2017. Xbiome specializes in microbial pharmaceuticals crafted to address microecological intestinal disorders. Employing artificial intelligence, the company swiftly analyzes both patient and donor gut flora to expedite the development of potent pharmaceuticals. Leveraging living biological drugs and microbial small molecule modulators, Xbiome empowers patients to attain relief or treatment for their conditions.

Do read about some of the most popular patents of Xbiome which have been covered by us in this article and also you can find Xbiome patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Xbiome patent portfolio.

How many patents does Xbiome have?

Xbiome has a total of 11 patents globally. These patents belong to 4 unique patent families. Out of 11 patents, all the patents are active.

How Many Patents did Xbiome File Every Year?

Xbiome Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantXbiome Applications FiledXbiome Patents Granted
20193
20207
20221

How many Xbiome patents are Alive/Dead?

All the Xbiome patents are alive.

How Many Patents did Xbiome File in Different Countries?

Xbiome Worldwide Patent Filing

Countries in which Xbiome Filed Patents

CountryPatent
United States of America5
China3
Europe (EPO)2
Hong Kong (S.A.R.)1

Where are Research Centers of Xbiome Patents Located?

The Research Centers of Xbiome Patents is the United States of America.

List of Xbiome patents

Xbiome PatentsTitle
US20200215129A1Methods And Compositions For Treating Gastrointestinal And Inflammatory Disorders
US20210060090A1Compositions Comprising Bacterial Species And Methods Related Thereto
US20220339212A1Compositions Comprising Bacterial Species And Methods Related Thereto
US20220409675A1Compositions Comprising Bacterial Species And Methods Related Thereto
US20230081756A1Compositions Comprising Bacterial Species And Methods Related Thereto
EP3870691A4Methods And Compositions For Treating Gastrointestinal And Inflammatory Disorders
EP4021467A4Compositions Comprising Bacterial Species And Methods Related Thereto
CN113728088AMethods And Compositions For Treating Gastrointestinal And Inflammatory Disorders
CN114728026ACompositions Comprising Bacterial Species And Methods Related Thereto
CN115243697ACompositions Comprising Bacterial Species And Methods Related Thereto
HK40076957ACompositions Comprising Bacterial Species And Methods Related Thereto

What are Xbiome key innovation segments?

What Technologies are Covered by Xbiome?

The chart below distributes patents filed by Xbiome in different countries on the basis of the technology protected in patents. It also represents the markets where Xbiome thinks it’s important to protect particular technology inventions.

R&D Focus: How has Xbiome search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Xbiome?

Related Articles

Aizant Patents – Insights & Stats (Updated 2024)

Aizant has a total of 64 patents globally, out of which 8 have been granted. Of these 64 patents, more than 45% patents are active. India is where Aizant has filed the maximum number of patents, followed by United States of America and Canada. Parallelly, India seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.